Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results

May 7, 2018

BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1st quarter 2018 financial results and business update. This call will be rescheduled for 8:30am ET on Tuesday, May 8, 2018.

The Company invites you to listen to the call by dialing (866) 393-8366.  International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website


Damian Finio
Teligent, Inc.
(856) 336-9117 

Primary Logo

Source: Teligent, Inc.